Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhGH and DHEA adjunct therapy in poor ovarian response or advanced-age women undergoing IVF-ET
ChiCTR-IPR-17012194Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Anhui Medical University
- Start
- Aug 2017
- Modality
- Recombinant Proteins and Enzymes, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of somatropin and dehydroepiandrosterone in infertility and poor ovarian response (POR) (2 arms), sponsored by First Affiliated Hospital of Anhui Medical University. Primary endpoint: IGF-1. Started Aug 2017; status: recruiting.
02
Drugs
somatropindehydroepiandrosterone
03
Conditions
infertilitypoor ovarian response (POR)
Beyond the preview
Go deeper on ChiCTR-IPR-17012194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17012194.